Xuanzhu Biopharmaceutical Co., Ltd. (HKG:2575)
Hong Kong · Delayed Price · Currency is HKD 35.10
-1.02 (-2.82%)
At close: Mar 27, 2026
Xuanzhu Biopharmaceutical Market Cap
Xuanzhu Biopharmaceutical has a market cap or net worth of 18.18 billion as of March 27, 2026.
Market Cap
18.18B
Enterprise Value
18.06B
Revenue
35.02M
Ranking
n/a
PE Ratio
n/a
Stock Price
35.10
Market Cap Chart
Since October 15, 2025, Xuanzhu Biopharmaceutical's market cap has increased from 13.62B to 18.18B, an increase of 33.46%. That is a compound annual growth rate of 90.85%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 27, 2026 | 18.18B | -50.21% |
| Dec 31, 2025 | 36.52B | 168.06% |
| Oct 15, 2025 | 13.62B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| China Medical System Holdings | 32.17B |
| Simcere Pharmaceutical Group | 31.18B |
| Sunshine Lake Pharma | 24.94B |
| Grand Pharmaceutical Group | 23.74B |
| OneRobotics (Shenzhen) | 23.00B |
| The United Laboratories International Holdings | 20.03B |
| Consun Pharmaceutical Group | 14.63B |
| CanSino Biologics | 13.10B |